1
Editorial More Donors Are Available—Why Don’t We Use Them? R. E. Chinnock* Department of Pediatrics, Loma Linda University, Loma Linda, California *Corresponding author: Richard E. Chinnock, [email protected] Received 25 January 2013, revised 16 February 2013 and accepted 23 February 2013 Children listed for heart transplantation face the highest wait-list mortality, at about 20%, of any solid organ transplant recipients (1). In light of this disturbing number, it is equally disturbing that only about half of all potential pediatric heart donors are utilized. Easterwood et al., in this edition of the journal, have provided their experience comparing donors who were turned down by other centers for poor donor quality with donors that they accepted primarily for transplantation (2). This joins our own recently published evaluation demonstrating the same finding, with a somewhat younger recipient pool (3). It is also consistent with a recent report (4) which detailed the lack of impact of CPR on the utility of the donor and a report from early in our experience where we reported the successful use of the dysfunctional donor heart (5). In light of these reports, one then must ask—Why there are still so many donors who are turned down for transplanta- tion? I believe the answer likely lies in the experience of many centers with a 10–15% incidence of early graft failure, often requiring ECMO to salvage the donor heart. In addition, since the number of transplants performed at any one center is small, one bad result can have a significant adverse impact on an individual center’s outcomes. With this in mind, and in particular for the child listed as UNOS status 2, there is an understandable reluctance to use what is perceived to be a marginal donor. And yet 50% of potential donors are not used in the face of 20% pre- transplant mortality. What should be the response of the pediatric heart transplant community? The current report by Eastwood et al. is a helpful contribution to the conversation. However, the process of deciding who is and who is not an acceptable donor is too often shrouded in personal experience and anecdote. It is time that a deeper, prospective multi-center evaluation be undertaken to establish just what param- eters, both from the donor (e.g. the use of biomarkers) (6) and the recipient, will maximize the outcome in pediatric heart transplantation. Disclosure The author of this manuscript has no conflicts of interest to disclose as described by the American Journal of Transplantation. References 1. Almond CS, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 2009; 119: 717–727. 2. Easterwood R, Singh RK, McFeely ED, et al. Pediatric cardiac transplantation using hearts previously refused for quality: A single center experience. Am J Transplant 2013; 13: 1484–1490. 3. Bailey LL, Razzouk AJ, Hasiniya NW, et al. Pediatric transplantation using hearts refused on the basis of donor quality. Ann Thorac Surg 2009; 87: 1902–1909. 4. L’Ecuyer T, Sloan K, Tang L. Impact of donor cardiopulmonary resuscitation on pediatric heart transplant outcome. Pediatr Transplant 2011; 15: 742–745. 5. Boucek MM, Mathis CM, Kanakriyeh MS, et al. Donor shortage: Use of the dysfunctional donor heart. J Heart Lung Transplant 1993; 12 (6 Pt 2): S186–S190. 6. Dronavalli VB, Banner NR, Bonser RS. Assessment of the potential heart donor: A role for biomarkers? J Am Coll Cardiol. 2010; 56: 352–361. American Journal of Transplantation 2013; 13: 1382 Wiley Periodicals Inc. C Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1002/ajt.12245 1382

More Donors Are Available-Why Don't We Use Them?

  • Upload
    r-e

  • View
    214

  • Download
    1

Embed Size (px)

Citation preview

Editorial

More Donors Are Available—Why Don’t WeUse Them?

R. E. Chinnock*

Department of Pediatrics, Loma Linda University,Loma Linda, California*Corresponding author: Richard E. Chinnock,[email protected]

Received 25 January 2013, revised 16 February 2013and accepted 23 February 2013

Children listed for heart transplantation face the highest

wait-list mortality, at about 20%, of any solid organ

transplant recipients (1). In light of this disturbing number,

it is equally disturbing that only about half of all potential

pediatric heart donors are utilized. Easterwood et al., in this

edition of the journal, have provided their experience

comparing donors who were turned down by other centers

for poor donor quality with donors that they accepted

primarily for transplantation (2). This joins our own recently

published evaluation demonstrating the same finding, with

a somewhat younger recipient pool (3). It is also consistent

with a recent report (4) which detailed the lack of impact of

CPR on the utility of the donor and a report from early in our

experience where we reported the successful use of the

dysfunctional donor heart (5).

In light of these reports, one thenmust ask—Why there are

still so many donors who are turned down for transplanta-

tion? I believe the answer likely lies in the experience of

many centerswith a 10–15% incidence of early graft failure,

often requiring ECMO to salvage the donor heart. In

addition, since the number of transplants performed at any

one center is small, one bad result can have a significant

adverse impact on an individual center’s outcomes. With

this in mind, and in particular for the child listed as UNOS

status 2, there is an understandable reluctance to use what

is perceived to be a marginal donor. And yet 50% of

potential donors are not used in the face of 20% pre-

transplant mortality.

What should be the response of the pediatric heart

transplant community? The current report by Eastwood

et al. is a helpful contribution to the conversation. However,

the process of decidingwho is andwho is not an acceptable

donor is too often shrouded in personal experience and

anecdote. It is time that a deeper, prospective multi-center

evaluation be undertaken to establish just what param-

eters, both from the donor (e.g. the use of biomarkers) (6)

and the recipient, will maximize the outcome in pediatric

heart transplantation.

Disclosure

The author of this manuscript has no conflicts of interest to

disclose as described by the American Journal of

Transplantation.

References

1. Almond CS, Thiagarajan RR, Piercey GE, et al. Waiting list mortality

among children listed for heart transplantation in the United States.

Circulation 2009; 119: 717–727.

2. Easterwood R, Singh RK, McFeely ED, et al. Pediatric cardiac

transplantation using hearts previously refused for quality: A single

center experience. Am J Transplant 2013; 13: 1484–1490.

3. Bailey LL, Razzouk AJ, Hasiniya NW, et al. Pediatric transplantation

using hearts refused on the basis of donor quality. Ann Thorac Surg

2009; 87: 1902–1909.

4. L’Ecuyer T, Sloan K, Tang L. Impact of donor cardiopulmonary

resuscitation on pediatric heart transplant outcome. Pediatr

Transplant 2011; 15: 742–745.

5. BoucekMM,Mathis CM, KanakriyehMS, et al. Donor shortage: Use

of the dysfunctional donor heart. J Heart Lung Transplant 1993; 12 (6

Pt 2): S186–S190.

6. DronavalliVB,BannerNR,BonserRS.Assessmentof thepotentialheart

donor: A role for biomarkers? J Am Coll Cardiol. 2010; 56: 352–361.

American Journal of Transplantation 2013; 13: 1382Wiley Periodicals Inc.

�C Copyright 2013 The American Society of Transplantationand the American Society of Transplant Surgeons

doi: 10.1002/ajt.12245

1382